The efficacy of targeted therapy and/or immunotherapy with or without chemotherapy in patients with Colorectal Cancer: A Network Meta-Analysis

H Guo, L Miao, C Yu - European Journal of Pharmacology, 2024 - Elsevier
Background The use of targeted drugs and immunotherapy has significantly impacted the
treatment of Colorectal Cancer. However, horizontal comparison among various regimens is …

Current practices in hepatic artery infusion (HAI) chemotherapy: an international survey of the HAI consortium research network

SJ Judge, T Ghalambor, MJ Cavnar, ME Lidsky… - Annals of surgical …, 2023 - Springer
Background An increasing number of hepatic artery infusion (HAI) programs have been
established worldwide. Practice patterns for this complex therapy across these programs …

Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection

Y Wang, X Bi, H Zhao, Z Li, J Zhao… - Oncology …, 2023 - spandidos-publications.com
This study aimed to investigate the prognostic value of the preoperative alkaline
phosphatase‑to‑albumin ratio (APAR) in patients with hepatocellular carcinoma (HCC) who …

A Modified floxuridine reduced-dose protocol for patients with unresectable colorectal liver metastases treated with hepatic arterial infusion

IR Schwantes, RK Patel, A Kardosh, J Paxton… - Annals of surgical …, 2024 - Springer
Background Most patients treated with the standard dosing protocol (SDP) of hepatic arterial
infusion (HAI) floxuridine require dose holds and reductions, thereby limiting their HAI …

经肝动脉输液泵化疗在结直肠癌肝转移治疗中的临床应用进展

马瑞东, 罗诗樵 - 实用肝脏病杂志, 2024 - manu43.magtech.com.cn
肝脏是结直肠癌血行转移最主要的靶器官, 约有50% 结直肠癌最终会发生肝转移,
肝转移已经成为影响结直肠癌患者预后的重要不利因素. 肝动脉是结直肠癌肝转移瘤的主要供血 …

Evaluation of biliary toxicity in patients with hepatic artery infusion pumps

J Elijah, AJ Schepers, JC Krauss… - Journal of Oncology …, 2023 - journals.sagepub.com
Purpose Identify risk factors for biliary toxicity in patients with colorectal liver metastases who
received floxuridine (FUDR) via a surgically implanted hepatic artery infusion pump (HAIP) …

[HTML][HTML] 电化学方法检测抗癌药物氟尿嘧啶的最新研究进展——新材料修饰电极助力提升检测效果

刘泽馨, 柳俊屹, 刘宇轩, 黄显博, 李梦珂… - Hans Journal of …, 2022 - hanspub.org
5-氟尿嘧啶自合成以来, 被广泛地应用于消化道癌和其他实体瘤的治疗. 虽然获得了很好的疗效,
然而, 它的毒副作用也越来越引起科研人员的重视. 为了进一步研究治疗过程中 …

ASO Author Reflections: Is It Time to Re-evaluate Floxuridine Dosing for Hepatic Arterial Infusion?

IR Schwantes, RK Patel, A Kardosh, CD Lopez… - Annals of surgical …, 2024 - Springer
When hepatic arterial infusion (HAI) was introduced in the 1980s, the initial enthusiasm was
tempered by complications, limiting widespread adoption. Afterward, a standard dosing …

Liver Metastases

AK Siriwardena - Bailey & Love's Essential Operations in …, 2024 - taylorfrancis.com
This chapter discusses the management of patients with liver metastases. The principal
focus is on the care of those with liver metastases from colorectal cancer. Here, the …

[PDF][PDF] FACULTY OF HEALTH SCIENCES SCHOOL OF MEDICINE

V Konstantina - 2023 - ikee.lib.auth.gr
1. History of the parathyroid glands.......................................……………….. 7 2. Anatomy and
Embryology……………………………………………………. 7 3. Physiology and …